Clinical Trials Directory

Trials / Completed

CompletedNCT00492661

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

A Pilot Trial of the Effect of Dietary and Exercise Intervention on Insulin Resistance and Metabolic Parameters in De Novo Renal Transplant Recipients on Prograf (Tacrolimus)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Janssen-Cilag Pty Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to investigate whether a combined dietary and exercise intervention, added to standard care, reduces the expected frequency of insulin resistance in renal (kidney) transplant recipients on tacrolimus.

Detailed description

This is an open-label (all people know the identity of the intervention), prospective (study following participants forward in time), single-arm, multi-center (conducted in more than 1 center), interventional pilot study of the effects of a combined dietary and exercise intervention on glucose metabolism. The duration of this study will be 6 months and will include following visits: Baseline, Week 4, Week 12, and Week 24. Dietary compliance will be evaluated with a 3-day food record and during weekly telephone conversations and face-to-face visits with a dietician. Exercise compliance will be measured using an exercise log presented to the co-ordinator at the end of each month. Primarily, participants with insulin resistance will be assessed by Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) of greater than 1 at 6 months. Participants' safety and tolerability will be monitored throughout the study.

Conditions

Interventions

TypeNameDescription
DRUGTacrolimus With Diet and Exercise InterventionParticipants on tacrolimus for immunosuppression will be provided with intensive dietary advice and supervised for a period of 6 months. Dosage and administration of tacrolimus will be as per Investigator's discretion.

Timeline

Start date
2007-07-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2007-06-27
Last updated
2013-05-27

Locations

4 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT00492661. Inclusion in this directory is not an endorsement.